Literature DB >> 12216425

Localization of the Fas-Fas ligand system in human fetal membranes.

Hassan M Harirah1, Sahar E Donia, Vanita Parkash, David C Jones, Chaur-Dong Hsu.   

Abstract

OBJECTIVE: To determine if fetal membranes might be one of the sources of Fas and Fas ligand in amniotic fluid. STUDY
DESIGN: Human fetal membranes from elective cesarean section (n = 6) were fixed in paraformaldehyde. Rolls of paraffinembedded fetal membranes were cut into 5-micron sections. After blocking with horse and goat sera, sections were incubated overnight with primary antibodies followed by the appropriate secondary antibodies. Avidin-biotin complex and diaminobenzidine were used for immunoperoxidase localization. Expression of Fas and Fas ligand was read by light microscopy.
RESULTS: Both Fas and Fas ligand were localized in amnion, chorion and decidual layers. In amnion, Fas and Fas ligand were expressed predominantly in epithelial cells and fibroblasts, while there was no immunostaining in the subepithelial compact connective tissue. In the chorion, the expression was mainly in the chorionic trophoblast, with inconsistent expression in the reticular layer. In the decidua, the expression of Fas and Fas ligand was less prominent than in amnion and chorion.
CONCLUSION: Localization of Fas and Fas ligand in human fetal membranes suggests that fetal membranes could be one of the sources of soluble Fas and Fas ligand in amniotic fluid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12216425

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Increased Apoptosis in Chorionic Trophoblasts of Human Fetal Membranes with Labor at Term.

Authors:  Hassan M Harirah; Mostafa A Borahay; Wahidu Zaman; Mahmoud S Ahmed; Gary Dv Hankins
Journal:  Int J Clin Med       Date:  2012

2.  Expression of tumor necrosis factor-alpha and vascular endothelial growth factor in different zones of fetal membranes: a possible relation to onset of labor.

Authors:  Amr K Elfayomy; Shaima M Almasry
Journal:  J Mol Histol       Date:  2014-06       Impact factor: 2.611

Review 3.  A Rational Strategy for the Use of Amniotic Epithelial Stem Cell Therapy for Liver Diseases.

Authors:  Toshio Miki
Journal:  Stem Cells Transl Med       Date:  2016-03-03       Impact factor: 6.940

4.  Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells.

Authors:  Fanny Lebreton; Reine Hanna; Charles H Wassmer; Kevin Bellofatto; Lisa Perez; Véronique Othenin-Girard; Begoña Martinez de Tejada; Marie Cohen; Ekaterine Berishvili
Journal:  Stem Cell Rev Rep       Date:  2021-10-06       Impact factor: 5.739

Review 5.  Human Amniotic Epithelial Stem Cells: A Promising Seed Cell for Clinical Applications.

Authors:  Chen Qiu; Zhen Ge; Wenyu Cui; Luyang Yu; Jinying Li
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.